FDA to Meet With Advocacy Groups on MDUFA Reauthorization

As part of its statutory requirements for the reauthorization of the Medical Device User Fee Amendments, the FDA will hold its first meeting with patient and consumer advocacy groups Jan. 13. The agency is required to meet with the advocacy groups on a monthly basis while it is negotiating the reauthorization with the device industry. Groups wanting to attend the first meeting should submit a notification of intention to participate by Jan. 6.